The government has established a committee to create rules for prosecuting chemists and retailers selling spurious drugs. This initiative a...

More than 50 drugs for common conditions like high blood pressure, acid reflux, and erectile dysfunction have been found to be not-of-stand...

India's drug regulator withdraws state licensing authorities' NOC issuance power for export of unapproved drugs due to substandard products...

Pharmaceutical companies that market medicines made by third parties in the country will now be held responsible for drug product quality w...

The surveys and reports point to the need for handling of the problem of substandard and counterfeit drugs .

A review of the annual reports of the country’s top 10 pharma companies shows that words like “counterfeit”, “spurious" or “fake” drugs do ...

There are usually 10,00 to one lakh units in a batch, but the number of drugs - which can be in the form of tablets or liquid - in a batch ...

According to the proposal, the sites will be inspected if they have made substandard drugs, received quality complaints, or faced action by...

The Pantocid and Pantocid DSR tested by CDSCO were not manufactured by Sun Pharma, the official spokesperson for the Mumbai-based drug make...

This result also implies that substandard drugs sold in India has dipped from 2011-2015, when roughly 4-5% of the total samples were declar...

Dinesh Thakur says the country needs strict criminal prosecution against suppliers of substandard drugs, a nationwide product recall system.

In his report, Thakur suggested greater empowerment for the central administration by amending certain legal provisions like Drugs and Cosm...

The former Madhya Pradesh chief minister alleged in the letter that there was a "nexus between the higher officials and supplier companies".

We need policy focus to provide standard quality and reasonable prices for the most essential medicines and not aim at ambitious regulatory...

The government has decided to initiate investigation against suspected exporters of substandard drugs on information provided by its missio...

The Drug Controller General of India (DCGI) is planning a survey to detect the quantum of spurious and substandard drugs being sold to unsu...

The scare over substandard drugs flooding the market is akin to making a mountain out of a molehill, says a nation-wide study funded by the...